← FDA Drug Approvals (Drugs@FDA)

LENALIDOMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2025-09-16

Drug application

FDA Application #
ANDA214398
Application type
Abbreviated New Drug Application (Generic)
Brand name
LENALIDOMIDE
Generic name
Lenalidomide
Active ingredients
LENALIDOMIDE
Dosage form
CAPSULE
Route
ORAL
Marketing status
Prescription
Sponsor
LUPIN
First approval
2025-09-16

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown